Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@TTRAmyloid Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::4405274772.png) @TTRAmyloid Not Odd

Not Odd posts on X about $arwr, $alny, $srpt, $regn the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::4405274772/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4405274772/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +169%
- X Year XXXXXXX +183%

### Mentions: XX [#](/creator/twitter::4405274772/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4405274772/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -X%
- X Months XXX +57%
- X Year XXX +236%

### Followers: XXXXX [#](/creator/twitter::4405274772/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4405274772/c:line/m:followers.svg)

- X Week XXXXX +0.08%
- X Month XXXXX +2.10%
- X Months XXXXX +32%
- X Year XXXXX +27%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::4405274772/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4405274772/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::4405274772/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX% [technology brands](/list/technology-brands)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$arwr](/topic/$arwr) #10, [$alny](/topic/$alny) #15, [$srpt](/topic/$srpt) 1.08%, [$regn](/topic/$regn) #39, [$rna](/topic/$rna) #19, [$abnb](/topic/$abnb) 0.54%, [$tpl](/topic/$tpl) 0.54%, [$rprx](/topic/$rprx) 0.54%, [$cytk](/topic/$cytk) 0.54%, [ip](/topic/ip) XXXX%

**Top accounts mentioned or mentioned by**
[@hall8jack](/creator/undefined) [@sanctuarybio](/creator/undefined) [@duedoctor](/creator/undefined) [@uchi_wawa](/creator/undefined) [@jcastillotan](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@bioinvestor24](/creator/undefined) [@machiavellicap](/creator/undefined) [@nociftw](/creator/undefined) [@persimmonti](/creator/undefined) [@artsstocks](/creator/undefined) [@theinsidersfund](/creator/undefined) [@auditor112017](/creator/undefined) [@evantindell](/creator/undefined) [@kirawontmiss](/creator/undefined) [@hannibalspeaks](/creator/undefined) [@biofeed](/creator/undefined) [@thebiotechbear](/creator/undefined) [@bion00b](/creator/undefined) [@melvinriskmgmt](/creator/undefined)

**Top assets mentioned**
[Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Airbnb Inc (ABNB)](/topic/$abnb) [Texas Pacific Land, Corp. (TPL)](/topic/$tpl) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Insmed, Inc. (INSM)](/topic/$insm) [Vertex Protocol (VRTX)](/topic/$vrtx) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Novartis AG (NVS)](/topic/$nvs) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx)
### Top Social Posts [#](/creator/twitter::4405274772/posts)
---
Top posts by engagements in the last XX hours

"@evantindell $abnb"  
[X Link](https://x.com/TTRAmyloid/status/1979212135147164145) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-17T15:45Z 1254 followers, XXX engagements


"$tpl oil royalty worth 45x earnings $rprx drug royalty thats growing XX% annual worth 8x earnings"  
[X Link](https://x.com/TTRAmyloid/status/1968740255860760805) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-09-18T18:13Z 1254 followers, 1081 engagements


"$arwr probably a good short. No IP company is worthless eventually"  
[X Link](https://x.com/TTRAmyloid/status/1975211253401612475) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-06T14:47Z 1244 followers, 4480 engagements


"Market is reappraising $ions. $ions a true Phil Fisher stock deserves the same positive appraisal as $alny and $argx"  
[X Link](https://x.com/TTRAmyloid/status/1975924156056162355) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-08T14:00Z 1251 followers, 1286 engagements


"Anyone know the best biotech focused mutual fund that can be bought in a self directed brokerage Most of the funds are so overweight to things like $alny $insm $lily and $vrtx"  
[X Link](https://x.com/TTRAmyloid/status/1976117487193457097) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-09T02:48Z 1251 followers, XXX engagements


"$srpt basically wants to give patients aids to get a gene therapy that doesnt work. Sounds like a really bad idea"  
[X Link](https://x.com/TTRAmyloid/status/1975929000695664844) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-08T14:19Z 1244 followers, XXX engagements


"$alny has been a terrible partner for $regn. Alny took regeneron money to work on their TTR assets. Regn is getting some 4th in class c5 inhibitor for myasthenia which is worthless because now you need X months to vaccinate before you can even start treatment. They also got a bunch of phase1 collaborations which has not moved out of P1 for like X years. And whats even more humiliating is that $alny market cap is larger than $regn now. Time for m&a $regn"  
[X Link](https://x.com/TTRAmyloid/status/1971716372012081569) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-09-26T23:19Z 1253 followers, 5533 engagements


"@ZwerBio $rna DM1 is a phase X trial for full approval and DMD44 is 10x better than anything sarepta has fshd already showing functional benefit. So this just solidifies their lead against $dyn and especially dog crap patent infringer $arwr/$srpt"  
[X Link](https://x.com/TTRAmyloid/status/1972711122613797297) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-09-29T17:12Z 1251 followers, 1999 engagements


"I think its pretty obvious now antisense RNA is the new modality for genetic based drugs. Not gene editing or aav gene replacement. This is the next platform after antibodies. What are you gonna do $regn"  
[X Link](https://x.com/TTRAmyloid/status/1975994298182074836) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-08T18:38Z 1254 followers, XXX engagements


"$nvs basically replaces their expiring entresto revenue with $rna acquisition for less than X years of entresto revenue"  
[X Link](https://x.com/TTRAmyloid/status/1955994626524934496) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-08-14T14:07Z 1251 followers, 1175 engagements


"@biobrainbox this is not the same at all. What reminds me of $Mltx is $arwr. No real innovation"  
[X Link](https://x.com/TTRAmyloid/status/1975599230330020255) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-07T16:28Z 1251 followers, XXX engagements


"@bioinvestor24 @ResearchPulse1 He doesnt like weight loss meds no way a GLP gets a voucher"  
[X Link](https://x.com/TTRAmyloid/status/1978940149523165377) [@TTRAmyloid](/creator/x/TTRAmyloid) 2025-10-16T21:44Z 1254 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@TTRAmyloid Avatar @TTRAmyloid Not Odd

Not Odd posts on X about $arwr, $alny, $srpt, $regn the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX +169%
  • X Year XXXXXXX +183%

Mentions: XX #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX -X%
  • X Months XXX +57%
  • X Year XXX +236%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.08%
  • X Month XXXXX +2.10%
  • X Months XXXXX +32%
  • X Year XXXXX +27%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXXX% technology brands XXXX% cryptocurrencies XXXX%

Social topic influence $arwr #10, $alny #15, $srpt 1.08%, $regn #39, $rna #19, $abnb 0.54%, $tpl 0.54%, $rprx 0.54%, $cytk 0.54%, ip XXXX%

Top accounts mentioned or mentioned by @hall8jack @sanctuarybio @duedoctor @uchi_wawa @jcastillotan @aaronrosenblum5 @bioinvestor24 @machiavellicap @nociftw @persimmonti @artsstocks @theinsidersfund @auditor112017 @evantindell @kirawontmiss @hannibalspeaks @biofeed @thebiotechbear @bion00b @melvinriskmgmt

Top assets mentioned Arrowhead Research Corporation (ARWR) Alnylam Pharmaceuticals, Inc. (ALNY) Sarepta Therapeutics, Inc. (SRPT) Regeneron Pharmaceuticals Inc (REGN) Avidity Biosciences, Inc. Common Stock (RNA) Airbnb Inc (ABNB) Texas Pacific Land, Corp. (TPL) Royalty Pharma plc Class A Ordinary Shares (RPRX) Cytokinetics Inc. (CYTK) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Insmed, Inc. (INSM) Vertex Protocol (VRTX) Dyne Therapeutics, Inc. Common Stock (DYN) Novartis AG (NVS) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

Top Social Posts #


Top posts by engagements in the last XX hours

"@evantindell $abnb"
X Link @TTRAmyloid 2025-10-17T15:45Z 1254 followers, XXX engagements

"$tpl oil royalty worth 45x earnings $rprx drug royalty thats growing XX% annual worth 8x earnings"
X Link @TTRAmyloid 2025-09-18T18:13Z 1254 followers, 1081 engagements

"$arwr probably a good short. No IP company is worthless eventually"
X Link @TTRAmyloid 2025-10-06T14:47Z 1244 followers, 4480 engagements

"Market is reappraising $ions. $ions a true Phil Fisher stock deserves the same positive appraisal as $alny and $argx"
X Link @TTRAmyloid 2025-10-08T14:00Z 1251 followers, 1286 engagements

"Anyone know the best biotech focused mutual fund that can be bought in a self directed brokerage Most of the funds are so overweight to things like $alny $insm $lily and $vrtx"
X Link @TTRAmyloid 2025-10-09T02:48Z 1251 followers, XXX engagements

"$srpt basically wants to give patients aids to get a gene therapy that doesnt work. Sounds like a really bad idea"
X Link @TTRAmyloid 2025-10-08T14:19Z 1244 followers, XXX engagements

"$alny has been a terrible partner for $regn. Alny took regeneron money to work on their TTR assets. Regn is getting some 4th in class c5 inhibitor for myasthenia which is worthless because now you need X months to vaccinate before you can even start treatment. They also got a bunch of phase1 collaborations which has not moved out of P1 for like X years. And whats even more humiliating is that $alny market cap is larger than $regn now. Time for m&a $regn"
X Link @TTRAmyloid 2025-09-26T23:19Z 1253 followers, 5533 engagements

"@ZwerBio $rna DM1 is a phase X trial for full approval and DMD44 is 10x better than anything sarepta has fshd already showing functional benefit. So this just solidifies their lead against $dyn and especially dog crap patent infringer $arwr/$srpt"
X Link @TTRAmyloid 2025-09-29T17:12Z 1251 followers, 1999 engagements

"I think its pretty obvious now antisense RNA is the new modality for genetic based drugs. Not gene editing or aav gene replacement. This is the next platform after antibodies. What are you gonna do $regn"
X Link @TTRAmyloid 2025-10-08T18:38Z 1254 followers, XXX engagements

"$nvs basically replaces their expiring entresto revenue with $rna acquisition for less than X years of entresto revenue"
X Link @TTRAmyloid 2025-08-14T14:07Z 1251 followers, 1175 engagements

"@biobrainbox this is not the same at all. What reminds me of $Mltx is $arwr. No real innovation"
X Link @TTRAmyloid 2025-10-07T16:28Z 1251 followers, XXX engagements

"@bioinvestor24 @ResearchPulse1 He doesnt like weight loss meds no way a GLP gets a voucher"
X Link @TTRAmyloid 2025-10-16T21:44Z 1254 followers, XXX engagements

@TTRAmyloid
/creator/twitter::TTRAmyloid